NASDAQ:CTSO
Cytosorbents Corporation Stock News
$0.93
+0.0500 (+5.68%)
At Close: May 06, 2024
CytoSorbents to Report Third Quarter 2022 Operating and Financial Results
07:00am, Thursday, 27'th Oct 2022
PRINCETON, N.J. , Oct. 27, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using b
Why fuboTV Shares Are Trading Higher By 11%; Here Are 22 Stocks Moving Premarket
10:52am, Tuesday, 18'th Oct 2022 Benzinga
Gainers
COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 78.1% to $0.0787 in pre-market trading after gaining 4% on Monday.
Zovio Inc (NASDAQ: ZVO) rose 60.2% to $0.2311 in pre-market trading af
Cytosorbents Corporation's (CTSO) CEO Phillip Chan on Q2 2022 Results - Earnings Call Transcript
11:03pm, Tuesday, 02'nd Aug 2022
Cytosorbents Corporation (NASDAQ:CTSO ) Q2 2022 Earnings Conference Call August 2, 2022 4:30 PM ET Company Participants Amy Vogel – Investor Relations Phillip Chan – Chief Executive Officer Kathle
CytoSorbents (CTSO) Reports Q2 Loss, Lags Revenue Estimates
10:35pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
CytoSorbents (CTSO) delivered earnings and revenue surprises of -78.57% and 11.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
CytoSorbents to Report Second Quarter 2022 Operating and Financial Results
07:00am, Monday, 25'th Jul 2022
PRINCETON, N.J. , July 25, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using
Abbott (ABT) Q2 Earnings and Revenues Top Estimates
12:45pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
Abbott (ABT) delivered earnings and revenue surprises of 31.19% and 8.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Stocks Under $3 Insiders Are Aggressively Buying
11:45am, Monday, 13'th Jun 2022 Benzinga
The Nasdaq Composite dropped by more than 400 points on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or co
3 Stocks Under $3 Insiders Are Aggressively Buying
07:54am, Monday, 13'th Jun 2022
The Nasdaq Composite dropped by more than 400 points on Friday. Investors, meanwhile, focused on some notable insider trades.
10 Top Penny Stocks To Buy In June According To These Insiders Part 1
06:54pm, Tuesday, 07'th Jun 2022 PennyStocks
Insiders are buying these penny stocks.
The post 10 Top Penny Stocks To Buy In June According To These Insiders Part 1 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.
10 Top Penny Stocks To Buy In June According To These Insiders Part 1
02:54pm, Tuesday, 07'th Jun 2022
Insiders are buying these penny stocks. The post 10 Top Penny Stocks To Buy In June According To These Insiders Part 1 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.
Cytosorbents Corporation (CTSO) CEO Phillip Chan on Q1 2022 Results - Earnings Call Transcript
12:11pm, Saturday, 07'th May 2022
Cytosorbents Corporation (NASDAQ:CTSO ) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Terri Anne Powers - Vice President, Investor Relations & Corporate Communications P
Cytosorbents Corporation (CTSO) CEO Phillip Chan on Q4 2021 Results - Earnings Call Transcript
02:50am, Wednesday, 09'th Mar 2022 Seeking AlphaCytosorbents Corporation (CTSO) CEO Phillip Chan on Q4 2021 Results - Earnings Call Transcript
09:50pm, Tuesday, 08'th Mar 2022
Cytosorbents Corporation (CTSO) CEO Phillip Chan on Q4 2021 Results - Earnings Call Transcript
CytoSorbents Reports Fourth Quarter and Full Year 2021 Results and Provides 2022 Outlook
09:15pm, Tuesday, 08'th Mar 2022 PR Newswire
MONMOUTH JUNCTION, N.J., March 8, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today…
CytoSorbents to Report Fourth Quarter and Full Year 2021 Operating and Financial Results
12:00pm, Tuesday, 08'th Feb 2022 PR Newswire
MONMOUTH JUNCTION, N.J., Feb. 8, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report fourth quarter and full year 2021 operating and…
